Key result
Percutaneous pulmonary valve replacement treats severe conduit degeneration at 16 weeks gestation in pulmonary atresia.
Why the study?
The number of women of childbearing age with congenital heart disease is increasing, and some pregnancies occur with unsuitable hemodynamics requiring intervention.
Case Report (n=1)
This case report describes the use of percutaneous pulmonary valve replacement in a pregnant woman with complex congenital heart disease and a degenerate conduit.
Case of unplanned pregnancy with unsuitable hemodynamics in congenital heart disease highlights risks; leaves open optimal preconception strategies.
T he number of women of childbearing age who have con- genital heart disease is increasing. 1 A similar proportion of these women can be expected to attempt pregnancy as women in general. 2 Although most of these women can be expected to tolerate pregnancy well, particularly if the pregnancy is carefully planned following appropriate clinical evaluation, not all pregnancies are planned, and some will occur in women with unsuitable hemodynamics.We report the case of a 21-year-old woman born with pulmonary atresia and a ventricular septal defect (VSD), ultimately palliated by a fenestrated closure of VSD and a valved homograft conduit placement between the right ventricle and the main pulmonary artery at the age of 3 years, who presented at 16 weeks gestation with a severely degenerate conduit.
No takes yet. Share an insight, caveat, or question.
Ormerod et al. (2014) conducted a case report in Degenerate pulmonary conduit during pregnancy (n=1). Percutaneous Pulmonary Valve Replacement was evaluated. A 21-year-old pregnant woman with pulmonary atresia and a ventricular septal defect presented at 16 weeks gestation with a severely degenerate conduit requiring percutaneous pulmonary valve replacement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: